α-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Gall, Walter E ^a   Beebe, Kirk ^a   Lawton, Kay A ^a   Adam, Klaus Peter ^a   Mitchell, Matthew W ^a   Nakhle, Pamela J ^a   Ryals, John A ^a   Milburn, Michael V ^a   Nannipieri, Monica ^b   Camastra, Stefania ^b   Natali, Andrea ^b   Ferrannini, Ele ^b  

^a METABOLON INC   (United States)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYBUTYRIC ACID; ACYLCARNITINE; AMINO ACID; BIOLOGICAL MARKER; CARBOXYLIC ACID; FATTY ACID; GLUCOSE; HYDROXYBUTYRIC ACID; INSULIN; LYSOPHOSPHOLIPID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CARDIOVASCULAR RISK; CLINICAL CHEMISTRY; CLINICAL CLASSIFICATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SYNTHESIS; ISOTOPE DILUTION ASSAY; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METABOLOMICS; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PATIENT IDENTIFICATION; RISK ASSESSMENT; RISK FACTOR;

EID: 77956293821     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010883     Document Type: Article

References (41)

1. Ginsberg H, Olefsky JM, Reaven GM (1974) Further evidence that insulin resistance exists in patients with chemical diabetes. Diabetes 23: 674-678.
2. Harris MI (1995) Epidemiologic studies on the pathogenesis of non-insulindependent diabetes mellitus (NIDDM). Clin Invest Med 18: 231-239.
3. Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, et al. (2008) Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 359: 2220-2232.
4. Reaven GM, Olefsky JM (1978) The role of insulin resistance in the pathogenesis of diabetes mellitus. Adv Metab Disord 9: 313-331.
5. Shen SW, Reaven GM, Farquhar JW (1970) Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest 49: 2151-2160.
6. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR (1990) Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113: 909-915.
7. DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194.
8. Ferrannini E, Balkau B, Coppack SW, Dekker JM, Mari A, et al. (2007) Insulin resistance, insulin response, and obesity as indicators of metabolic risk. J Clin Endocrinol Metab 92: 2885-2892.
9. Ginsberg HN (2000) Insulin resistance and cardiovascular disease. J Clin Invest 106: 453-458.
10. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, et al. (1996) Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 93: 1809-1817.
11. Yip J, Facchini FS, Reaven GM (1998) Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 83: 2773-2776.
12. Abdul-Ghani MA, DeFronzo RA (2009) Pathophysiology of prediabetes. Curr Diab Rep 9: 193-199.
13. Defronzo RA (2009) Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58: 773-795.
14. Reaven GM (1999) Insulin resistance: a chicken that has come to roost. Ann N Y Acad Sci 892: 45-57.
15. Reaven GM, Chen YI, Coulston AM, Greenfield MS, Hollenbeck C, et al. (1983) Insulin secretion and action in noninsulin-dependent diabetes mellitus. Is insulin resistance secondary to hypoinsulinemia? Am J Med 75: 85-93.
16. Bergman RN (2007) Orchestration of glucose homeostasis: from a small acorn to the California oak. Diabetes 56: 1489-1501.
17. Muniyappa R, Lee S, Chen H, Quon MJ (2008) Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 294: E15-26.
18. Boudonck KJ, Mitchell MW, Nemet L, Keresztes L, Nyska A, et al. (2009) Discovery of metabolomics biomarkers for early detection of nephrotoxicity. Toxicol Pathol 37: 280-292.
19. Lawton KA, Berger A, Mitchell M, Milgram KE, Evans AM, et al. (2008) Analysis of the adult human plasma metabolome. Pharmacogenomics 9: 383-397.
20. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, et al. (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457: 910-914.
21. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, et al. (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354: 2552-2563.
22. Kim SH, Reaven GM (2008) Insulin resistance and hyperinsulinemia: you can't have one without the other. Diabetes Care 31: 1433-1438.
23. Natali A, Taddei S, Quinones Galvan A, Camastra S, Baldi S, et al. (1997) Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension. Circulation 96: 849-855.
24. Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30: 89-94.
25. Landaas S (1975) The formation of 2-hydroxybutyric acid in experimental animals. Clin Chim Acta 58: 23-32.
26. Rosalki SB, Wilkinson JH (1960) Reduction of alpha-ketobutyrate by human serum. Nature 188: 1110-1111.
27. Pettersen JE, Landaas S, Eldjarn L (1973) The occurrence of 2-hydroxybutyric acid in urine from patients with lactic acidosis. Clin Chim Acta 48: 213-219.
28. Lord RS, Bralley JA (2008) Clinical applications of urinary organic acids. Part I: Detoxification markers. Altern Med Rev 13: 205-215.
29. Altmaier E, Ramsay SL, Graber A, Mewes HW, Weinberger KM, et al. (2008) Bioinformatics analysis of targeted metabolomics-uncovering old and new tales of diabetic mice under medication. Endocrinology 149: 3478-3489.
30. Brass EP (1986) Effect of alpha-ketobutyrate on palmitic acid and pyruvate metabolism in isolated rat hepatocytes. Biochim Biophys Acta 888: 18-24.
31. Landaas S, Pettersen JE (1975) Clinical conditions associated with urinary excretion of 2-hydroxybutyric acid. Scand J Clin Lab Invest 35: 259-266.
32. Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, et al. (2007) A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics 29: 99-108.
33. Silva AR, Ruschel C, Helegda C, Wyse AT, Wannmacher CM, et al. (2001) Inhibition of in vitro CO2 production and lipid synthesis by 2-hydroxybutyric acid in rat brain. Braz J Med Biol Res 34: 627-631.
34. Yang W, Roth KS (1985) Defect in alpha-ketobutyrate metabolism: a new inborn error. Clin Chim Acta 145: 173-182.
35. Paolisso G, Giugliano D, Pizza G, Gambardella A, Tesauro P, et al. (1992) Glutathione infusion potentiates glucose-induced insulin secretion in aged patients with impaired glucose tolerance. Diabetes Care 15: 1-7.
36. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, et al. (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9: 311-326.
37. Tremblay F, Lavigne C, Jacques H, Marette A (2007) Role of dietary proteins and amino acids in the pathogenesis of insulin resistance. Annu Rev Nutr 27: 293-310.
38. Hills S, Balkau B, Coppack S, Dekker J, Mari A, et al. (2004) The EGIR-RISC STUDY (The European Group for the Study of Insulin Resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Diabetologia 47: 566-570.
39. Evans AM, Dehaven CD, Barrett T, Mitchell M, Milgram E. (2009) Integrated, Nontargeted Ultrahigh Performance Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry Platform for the Identification and Relative Quantification of the Small-Molecule Complement of Biological Systems. Anal Chem.
40. Breiman L (2001) Random Forest. Machine Learning 45: 5-32.
41. Liaw A, Wiener M (2002) Classification and Regression by random Forest. R News 2: 18-22.